psalexa
SearchBar Icon

Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics Pipeline Analysis 2017
Published Report Code Available Format Pages
 July 2017  LS11104    124

Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation

Place an order

USD 2200
USD 2600
USD 3950